Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Accenture
McKinsey
Farmers Insurance
QuintilesIMS
Teva

Generated: May 21, 2019

DrugPatentWatch Database Preview

QUARTETTE Drug Profile

« Back to Dashboard

When do Quartette patents expire, and when can generic versions of Quartette launch?

Quartette is a drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-four patent family members in thirteen countries.

The generic ingredient in QUARTETTE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Drug patent expirations by year for QUARTETTE
Synonyms for QUARTETTE
110541-57-6
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-, mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-(+-)-, mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-(+-)-,mixt. with (17-alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
37263-36-8
39366-37-5
52232-43-6
55927-62-3
70208-30-9
8056-51-7
8063-84-1
8064-50-4
AC1L2NM9
Adepal
AG 200-15
AG200-15
aless
Alesse 28
Altavera
Anna
Anteovin
aviane
AVIANE-21
Aviane-21Fe
AVIANE-28
Biphasil
Biphasil 21
Biphasil 28
C21H28O2.C20H24O2
CCRIS 7261
CRYSELLE
dl-Norgestrel mixed with ethinylestradiol
DTXSID90192569
Duoluton
Ediwal
Elifemme
ENPRESSE-21
ENPRESSE-28
Ethinyl estradiol mixed with norgestrel
Ethinyl estradiol mixture with levonorgestrel
Ethinyl estradiol mixture with norgestrel
ETHINYL ESTRADIOL-NORGESTREL COMBINATION
ethinyl estradiol, levonorgestrel drug combination
Ethinyl estradiol/levonorgestrel
Ethinylestradiol - levonorgestrel mixt
Ethinylestradiol - levonorgestrel mixt.
Ethinylestradiol mixed with dl-norgestrel
Ethinylestradiol mixture with Levonorgestrel
Ethinyloestradiol mixed with norgestrel
Eugynon
Eugynon 30
Femenal
Follimin
Follinett
Follinyl
Gravistat
Gynatrol
Introvale
Jolessa
LESSINA-21
LESSINA-28
LEVLITE
Levonest
Levonorgestrel - ethynylestradiol mixt
Levonorgestrel - ethynylestradiol mixt.
Levonorgestrel and Ethinyl Estradiol
Levonorgestrel and Ethinyl Estradiol tablets
Levonorgestrel-ethinyl estradiol mixt
Levonorgestrel-ethinyl estradiol mixt.
Levonorgestrel, ethinyl estradiol
Levonorgestrel/ethinyl estradiol
Levora
LEVORA 0.15/30-21
LEVORA 0.15/30-28
Lo-Femenal
LO/OVRAL-28
LOC 31
LOC 31A
Logynon
Loseasonique
Low-ogestrel
LOW-OGESTREL-21
LOW-OGESTREL-28
LS-62088
LS-62092
Lybrel
Marlissa
Microgynon
Microgynon 30
Microvlar 30
Minidril
Minigynon
Minisiston
Neogynon
Neovlar
Neovletta
NORDETTE-21
NORDETTE-28
Nordiol
Nordiol-28
Norgestrel and Ethinyl Estradiol
Norgestrel mixed with ethinyl estradiol
Norgestrel mixed with ethinyloestradiol
Norgestrel-ethinyl estradiol
Norgestrel-Ethinyl Estradiol Combination
Norgestrel-ethynylestradiol mixt
Norgestrel-ethynylestradiol mixt.
OGESTREL 0.5/50-21
OGESTREL 0.5/50-28
Orasecron
Ovidon
Ovral 21
Ovral 28
Ovral L
OVRAL-28
Ovran
Ovranett
PC 4 (contraceptive)
Pearl Oral Contraceptive
Portia
PORTIA-21
PORTIA-28
PREVEN EMERGENCY CONTRACEPTIVE KIT
Primovlar
Pro-Duosterone
Quasense
Rigevidon
SCHEMBL4451192
Schering PC 4
Sequilar
Sequilarum
Sequostat
SH 71121
SH D00264A
SHB 261AB
SHB 264AB
Sronyx
Stederil 30
Stediril
Stediril D
Tri-Regol
Trigynon
Trikvilar
Trinordiol
Triphasil-21
TRIPHASIL-28
Triquilar
Trisiston
Trisistone R
Trisistone-R
TRIVORA-21
TRIVORA-28
Twirla
Vienva
WL 33
WY-E 104

US Patents and Regulatory Information for QUARTETTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061-001 Mar 28, 2013 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061-001 Mar 28, 2013 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for QUARTETTE
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg ➤ Subscribe ➤ Try a Free Trial

Supplementary Protection Certificates for QUARTETTE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1214076 C01214076/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
1453521 15C0050 France ➤ Try a Free Trial PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129
0136011 2000C/027 Belgium ➤ Try a Free Trial PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
1380301 CA 2009 00017 Denmark ➤ Try a Free Trial PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Federal Trade Commission
Queensland Health
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.